OrbiMed’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q2 | – | Sell |
|
|||||
2019
Q1 | $27.8M | Sell |
|
|||||
2018
Q4 | $209M | Buy |
|
|||||
2018
Q3 | $220M | Sell |
|
|||||
2018
Q2 | $204M | Sell |
|
|||||
2018
Q1 | $235M | Sell |
|
|||||
2017
Q4 | $320M | Sell |
|
|||||
2017
Q3 | $489M | Sell |
|
|||||
2017
Q2 | $445M | Buy |
|
|||||
2017
Q1 | $390M | Buy |
|
|||||
2016
Q4 | $360M | Buy |
|
|||||
2016
Q3 | $308M | Buy |
|
|||||
2016
Q2 | $237M | Sell |
|
|||||
2016
Q1 | $378M | Buy |
|
|||||
2015
Q4 | $439M | Buy |
|
|||||
2015
Q3 | $389M | Sell |
|
|||||
2015
Q2 | $443M | Buy |
|
|||||
2015
Q1 | $366M | Sell |
|
|||||
2014
Q4 | $409M | Buy |
|
|||||
2014
Q3 | $315M | Buy |
|
|||||
2014
Q2 | $228M | Sell |
|
|||||
2014
Q1 | $191M | Sell |
|
|||||
2013
Q4 | $297M | Buy |
|
|||||
2013
Q3 | $201M | Buy |
|
|||||
2013
Q2 | $145M | Buy |
|